An expert in environmental toxins at The University of Nottingham has developed a new antifungal technology which has the potential to play a major role in securing future food supplies.
Blocking fungal growth
Professor Simon Avery from the University’s Faculty of Medicine and Health Sciences has discovered that two agents, when combined, affect the process of protein synthesis, and have the potential to effectively block fungal growth in certain types of fungi which cause disease in crops or in humans.
Crop losses due to fungal spoilage each year are equivalent to the amount of food that could feed up to four billion people. In the developed world, millions of tonnes of crops are ruined each year by fungi and the problem is especially acute in developing countries where access to fungicides is more limited.
One of the problems with fungicides is that in many cases, the fungi adapt to the treatment, which means that most fungicides are only effective for a limited period. The solution developed by the University uses two agents which should make it more difficult for the fungi to acquire resistance to the fungicide.
Explaining how the technology works, Professor Avery said: “Protein synthesis is essential to enable organisms to grow. When these two agents are applied it causes errors in the synthesis process that stop the fungus growing.”
After making the breakthrough discovery, which is patented by the University, Professor Avery and his team received initial development support through the University’s HERMES scheme. This enabled him to secure additional funding from the Biotechnology and Biological Science and Research Council (BBSRC) to further develop the technology. Field trials will take place this summer to study the impact of the fungicides on crops which are subjected to different environmental conditions.
Read more: Breakthrough dual fungicide technology could help prevent crop failures
The Latest on: Antifungal technology
[google_news title=”” keyword=”Antifungal technology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antifungal technology
- 2023-2029 Polyene Antifungal Drugs API Market Size and Industrial Overview with Market Drivers | Latest Report by Absolute Reportson March 28, 2023 at 4:15 am
Mar 28, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The "Polyene Antifungal Drugs API ...
- Fungal Infections On The Rise: Antifungal Drugs Market Expected To Expand As Research And Development Efforts Intensifyon March 24, 2023 at 5:04 am
Antifungal Drugs Market generated $16.6 billion in 2020, and is projected to reach $25.0 billion by 2030, witnessing a CAGR of 3.9% from 2021 to 2030. PORTLAND, OREGON, UNITED STATES, March 24 ...
- FDA Approves Long-Acting Antifungal for Treating Candidaon March 23, 2023 at 12:00 pm
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA gave the greenlight to the long-acting antifungal rezafungin (Rezzayo), the first new treatment option for ...
- Cidara stock dips amid FDA approval of antifungal drug Rezzayoon March 23, 2023 at 9:29 am
The U.S. Food and Drug Administration (FDA) approved Cidara Therapeutics (NASDAQ:CDTX) and Melinta Therapeutics' Rezzayo (rezafungin for injection) to treat candidemia and invasive candidiasis in ...
- Cidara off 27% despite FDA nod amid selloff in antifungal spaceon March 23, 2023 at 8:43 am
- Chatbots Could Transform Medical Care — But Not in the Way You Thinkon March 23, 2023 at 3:00 am
Recent AI advancements could shift how we interact with healthcare providers — and even make the conversations more human.
- Antifungal tolerance in Candida auris contributes to treatment failureon March 22, 2023 at 5:00 pm
Please use one of the following formats to cite this article in your essay, paper or report: APA Bose, Priyom. (2023, March 23). Antifungal tolerance in Candida auris contributes to treatment ...
- Cidara gets US FDA approval for antifungal drugon March 22, 2023 at 3:25 pm
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo March 22 (Reuters) - The U.S. Food and ...
- 'Urgent threat': CDC warns against Candida auris, a drug-resistant fungus invading health care facilitieson March 21, 2023 at 8:34 am
auris), which is resistant to several antifungal medications ... It’s also difficult to identify without specialized laboratory technology and is often mistaken for other infections.
- Ringworm Treatmenton March 20, 2023 at 5:00 pm
If the infection is on your skin – as in the case of athlete’s foot or jock itch – your doctor will likely suggest an OTC antifungal cream, lotion, or powder. Clotrimazole (Lotrimin ...
via Bing News